Chemicals
Showing 12901–13050 of 41137 results
-
The calpains are a family of calcium-dependent cysteine proteases that catalyze limited proteolysis of substrates.{13816} Calpain Inhibitor III is a cell permeable, selective inhibitor of μ-calpain (calpain-1) and m-calpain (calpain-2).{22713} Calpain Inhibitor III crosses the blood-brain barrier to inhibit brain cysteine protease activity and has been reported to have neuroprotective effects in numerous rodent neurotrauma models, including spinal cord injury, cortical impact trauma, neonatal hypoxia-ischemia, and focal cerebral ischemia.{22714} Additionally, Calpain Inhibitor III has been shown to attenuate depression in myocardial contractile performance that occurs during reperfusion following cardiac ischemia.{22712}
Brand:CaymanSKU:-
Calpain inhibitor VI is an inhibitor of the calcium-dependent cysteine proteases µ-calpain (calpain-1; IC50 = 7.5 nM) and m-calpain (calpain-2; IC50 = 78 nM). It also inhibits cathepsins B and L (IC50s = 15 and 1.6 nM, respectively).{38603} It is selective for these calpains and cathepsins over other cysteine and serine proteases, factor VIIa, factor Xa, trypsin, chymotrypsin, and proteasome. In an in vitro porcine model of cataract, calpain inhibitor VI decreases the degree of cataract by 40% when used at a concentration of 0.8 µM.{38602} It also prevents cataract formation induced by selenite in rats when administered at a dose of 100 mg/kg for 4 days.{38604} Calpain inhibitor VI improves functional outcome and reduces apoptotic cell death in a rat model of spinal cord injury.{38601}
Brand:CaymanSKU:23942 - 1 mgAvailable on backorder
Calpain inhibitor XII is a reversible and selective inhibitor of calpain I (μ-calpain, Ki = 19 nM), with lower affinities for calpain II (m-calpain, Ki = 120 nM) and cathepsin B (Ki = 750 nM).{23178} Calpain inhibitors, including this compound, have been used to study the role of calpains in diverse processes, including neutrophil chemotaxis, neuronal signaling, and cardiac response to injury.{23174,23175,23177,23179}
Brand:CaymanSKU:- Calpain inhibitor XII is a reversible and selective inhibitor of calpain I (μ-calpain, Ki = 19 nM), with lower affinities for calpain II (m-calpain, Ki = 120 nM) and cathepsin B (Ki = 750 nM).{23178} Calpain inhibitors, including this compound, have been used to study the role of calpains in diverse processes, including neutrophil chemotaxis, neuronal signaling, and cardiac response to injury.{23174,23175,23177,23179}
Brand:CaymanSKU:- Calpain inhibitor XII is a reversible and selective inhibitor of calpain I (μ-calpain, Ki = 19 nM), with lower affinities for calpain II (m-calpain, Ki = 120 nM) and cathepsin B (Ki = 750 nM).{23178} Calpain inhibitors, including this compound, have been used to study the role of calpains in diverse processes, including neutrophil chemotaxis, neuronal signaling, and cardiac response to injury.{23174,23175,23177,23179}
Brand:CaymanSKU:-
Calpeptin is a cell-penetrating peptide inhibitor of calpain (IC50 = 5 nM) which completely abolishes calpain activity in platelets.{23055,23057,23056} In this way, it inhibits both collagen- and thrombin-induced aggregation of platelets.{22713} Calpeptin is also a potent inhibitor of cathepsin K (IC50 = 0.11 nM).{23058}
Brand:CaymanSKU:- Calpeptin is a cell-penetrating peptide inhibitor of calpain (IC50 = 5 nM) which completely abolishes calpain activity in platelets.{23055,23057,23056} In this way, it inhibits both collagen- and thrombin-induced aggregation of platelets.{22713} Calpeptin is also a potent inhibitor of cathepsin K (IC50 = 0.11 nM).{23058}
Brand:CaymanSKU:- Calpeptin is a cell-penetrating peptide inhibitor of calpain (IC50 = 5 nM) which completely abolishes calpain activity in platelets.{23055,23057,23056} In this way, it inhibits both collagen- and thrombin-induced aggregation of platelets.{22713} Calpeptin is also a potent inhibitor of cathepsin K (IC50 = 0.11 nM).{23058}
Brand:CaymanSKU:- Calpeptin is a cell-penetrating peptide inhibitor of calpain (IC50 = 5 nM) which completely abolishes calpain activity in platelets.{23055,23057,23056} In this way, it inhibits both collagen- and thrombin-induced aggregation of platelets.{22713} Calpeptin is also a potent inhibitor of cathepsin K (IC50 = 0.11 nM).{23058}
Brand:CaymanSKU:-
Calphostin C is a metabolite of the fungus C. cladosporioides that specifically inhibits protein kinase C (PKC) (IC50 = 50 nM versus an IC50 > 50 μM for PKA) by competing at the binding site for diacylglycerol and phorbol esters.{24915} As a polycyclic hydrocarbon with strong absorbance in the visible and ultraviolet ranges, activation of this compound is strictly dependent on exposure to light.{24913} Independent of PKC, calphostin C also directly inhibits phospholipase D1 and D2 (IC50s = 100 nM).{24914} It demonstrates antitumor activity, inhibiting cell growth and promoting apoptosis in HeLa S3 and MCF-7 cells with IC50 values of 0.23 and 0.18 μM, respectively.{24915}
Brand:CaymanSKU:- Calphostin C is a metabolite of the fungus C. cladosporioides that specifically inhibits protein kinase C (PKC) (IC50 = 50 nM versus an IC50 > 50 μM for PKA) by competing at the binding site for diacylglycerol and phorbol esters.{24915} As a polycyclic hydrocarbon with strong absorbance in the visible and ultraviolet ranges, activation of this compound is strictly dependent on exposure to light.{24913} Independent of PKC, calphostin C also directly inhibits phospholipase D1 and D2 (IC50s = 100 nM).{24914} It demonstrates antitumor activity, inhibiting cell growth and promoting apoptosis in HeLa S3 and MCF-7 cells with IC50 values of 0.23 and 0.18 μM, respectively.{24915}
Brand:CaymanSKU:-
Calpinactam is a fungal metabolite originally isolated from M. alpina that has antimycobacterial activity.{48246} It is active against M. smegmatis (MIC = 0.78 μg/ml) but not a panel of 13 other bacteria and fungi. Calpinactam increases survival in a silkworm model of M. smegmatis infection (ED50 = 5 μg/larva).{48247}
Brand:CaymanSKU:27735 - 1 mgAvailable on backorder
Calpinactam is a fungal metabolite originally isolated from M. alpina that has antimycobacterial activity.{48246} It is active against M. smegmatis (MIC = 0.78 μg/ml) but not a panel of 13 other bacteria and fungi. Calpinactam increases survival in a silkworm model of M. smegmatis infection (ED50 = 5 μg/larva).{48247}
Brand:CaymanSKU:27735 - 5 mgAvailable on backorder
Calpinactam is a fungal metabolite originally isolated from M. alpina that has antimycobacterial activity.{48246} It is active against M. smegmatis (MIC = 0.78 μg/ml) but not a panel of 13 other bacteria and fungi. Calpinactam increases survival in a silkworm model of M. smegmatis infection (ED50 = 5 μg/larva).{48247}
Brand:CaymanSKU:27735 - 500 µgAvailable on backorder
CALX8 is a calixarene detergent that has been used to solubilize membrane proteins.{41704} It has a critical micelle concentration (CMC) of 2.2 mM.
Brand:CaymanSKU:24777 - 100 mgAvailable on backorder
CALX8 is a calixarene detergent that has been used to solubilize membrane proteins.{41704} It has a critical micelle concentration (CMC) of 2.2 mM.
Brand:CaymanSKU:24777 - 250 mgAvailable on backorder
CALX8 is a calixarene detergent that has been used to solubilize membrane proteins.{41704} It has a critical micelle concentration (CMC) of 2.2 mM.
Brand:CaymanSKU:24777 - 50 mgAvailable on backorder
Brand:CaymanSKU:24783 - 10 mgAvailable on backorder
Brand:CaymanSKU:24783 - 50 mgAvailable on backorder
CALXGLUK is a calixarene detergent that can be used to solubilize membrane proteins.{41704} It has a critical micelle concentration (CMC) of 0.025 mM. CALXGLUK has been used to solubilize a membrane GPCR (MP-A) and a membrane transporter (MP-B) from yeast alone and in combination with Triton X-100 (Item No. 600217) and digitonin (Item No. 14952).
Brand:CaymanSKU:24784 - 10 mgAvailable on backorder
CALXGLUK is a calixarene detergent that can be used to solubilize membrane proteins.{41704} It has a critical micelle concentration (CMC) of 0.025 mM. CALXGLUK has been used to solubilize a membrane GPCR (MP-A) and a membrane transporter (MP-B) from yeast alone and in combination with Triton X-100 (Item No. 600217) and digitonin (Item No. 14952).
Brand:CaymanSKU:24784 - 100 mgAvailable on backorder
CALXGLUK is a calixarene detergent that can be used to solubilize membrane proteins.{41704} It has a critical micelle concentration (CMC) of 0.025 mM. CALXGLUK has been used to solubilize a membrane GPCR (MP-A) and a membrane transporter (MP-B) from yeast alone and in combination with Triton X-100 (Item No. 600217) and digitonin (Item No. 14952).
Brand:CaymanSKU:24784 - 50 mgAvailable on backorder
Calycosin is an isoflavone and phytoestrogen with diverse biological activities.{41872,41873,41874,43143,41875,41876} It is an estrogen receptor (ER) partial agonist that inhibits 17β-estradiol binding to ERα and ERβ (IC50s = 83.14 and 40.38 μM, respectively).{41872} Calycosin induces tube formation by human umbilical vein endothelial cells (HUVECs) in a Matrigel™ assay and angiogenesis in zebrafish via activation of ERs and ERK1/2. It has antiplasmodial and antiprotozoal activities, reducing the growth of the poW and Dd2 strains of P. falciparum (IC50s = 4.2 and 9.8 μg/ml, respectively) and exhibiting selective toxicity for T. brucei brucei over Vero cells (IC50s = 12.7 and 159 μM, respectively).{41873,41874} Calycosin scavenges 2,2-diphenyl-1-picrylhydrazyl (DPPH; Item No. 14805) free radicals in a cell-free assay and inhibits xanthine/xanthine oxidase-induced toxicity in PC12 cells (EC50 = 50 ng/ml).{43143} In vivo, calycosin (12.5 and 25 mg/kg) reduces alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity, triglyceride accumulation, and hepatic fibrosis in a mouse model of non-alcoholic steatohepatitis (NASH).{41875} It also decreases infarct volume and brain edema in a rat model of focal cerebral ischemia and reperfusion injury.{41876}
Brand:CaymanSKU:25091 - 10 mgAvailable on backorder
Calycosin is an isoflavone and phytoestrogen with diverse biological activities.{41872,41873,41874,43143,41875,41876} It is an estrogen receptor (ER) partial agonist that inhibits 17β-estradiol binding to ERα and ERβ (IC50s = 83.14 and 40.38 μM, respectively).{41872} Calycosin induces tube formation by human umbilical vein endothelial cells (HUVECs) in a Matrigel™ assay and angiogenesis in zebrafish via activation of ERs and ERK1/2. It has antiplasmodial and antiprotozoal activities, reducing the growth of the poW and Dd2 strains of P. falciparum (IC50s = 4.2 and 9.8 μg/ml, respectively) and exhibiting selective toxicity for T. brucei brucei over Vero cells (IC50s = 12.7 and 159 μM, respectively).{41873,41874} Calycosin scavenges 2,2-diphenyl-1-picrylhydrazyl (DPPH; Item No. 14805) free radicals in a cell-free assay and inhibits xanthine/xanthine oxidase-induced toxicity in PC12 cells (EC50 = 50 ng/ml).{43143} In vivo, calycosin (12.5 and 25 mg/kg) reduces alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity, triglyceride accumulation, and hepatic fibrosis in a mouse model of non-alcoholic steatohepatitis (NASH).{41875} It also decreases infarct volume and brain edema in a rat model of focal cerebral ischemia and reperfusion injury.{41876}
Brand:CaymanSKU:25091 - 25 mgAvailable on backorder
Calycosin is an isoflavone and phytoestrogen with diverse biological activities.{41872,41873,41874,43143,41875,41876} It is an estrogen receptor (ER) partial agonist that inhibits 17β-estradiol binding to ERα and ERβ (IC50s = 83.14 and 40.38 μM, respectively).{41872} Calycosin induces tube formation by human umbilical vein endothelial cells (HUVECs) in a Matrigel™ assay and angiogenesis in zebrafish via activation of ERs and ERK1/2. It has antiplasmodial and antiprotozoal activities, reducing the growth of the poW and Dd2 strains of P. falciparum (IC50s = 4.2 and 9.8 μg/ml, respectively) and exhibiting selective toxicity for T. brucei brucei over Vero cells (IC50s = 12.7 and 159 μM, respectively).{41873,41874} Calycosin scavenges 2,2-diphenyl-1-picrylhydrazyl (DPPH; Item No. 14805) free radicals in a cell-free assay and inhibits xanthine/xanthine oxidase-induced toxicity in PC12 cells (EC50 = 50 ng/ml).{43143} In vivo, calycosin (12.5 and 25 mg/kg) reduces alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity, triglyceride accumulation, and hepatic fibrosis in a mouse model of non-alcoholic steatohepatitis (NASH).{41875} It also decreases infarct volume and brain edema in a rat model of focal cerebral ischemia and reperfusion injury.{41876}
Brand:CaymanSKU:25091 - 5 mgAvailable on backorder
Calycosin is an isoflavone and phytoestrogen with diverse biological activities.{41872,41873,41874,43143,41875,41876} It is an estrogen receptor (ER) partial agonist that inhibits 17β-estradiol binding to ERα and ERβ (IC50s = 83.14 and 40.38 μM, respectively).{41872} Calycosin induces tube formation by human umbilical vein endothelial cells (HUVECs) in a Matrigel™ assay and angiogenesis in zebrafish via activation of ERs and ERK1/2. It has antiplasmodial and antiprotozoal activities, reducing the growth of the poW and Dd2 strains of P. falciparum (IC50s = 4.2 and 9.8 μg/ml, respectively) and exhibiting selective toxicity for T. brucei brucei over Vero cells (IC50s = 12.7 and 159 μM, respectively).{41873,41874} Calycosin scavenges 2,2-diphenyl-1-picrylhydrazyl (DPPH; Item No. 14805) free radicals in a cell-free assay and inhibits xanthine/xanthine oxidase-induced toxicity in PC12 cells (EC50 = 50 ng/ml).{43143} In vivo, calycosin (12.5 and 25 mg/kg) reduces alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity, triglyceride accumulation, and hepatic fibrosis in a mouse model of non-alcoholic steatohepatitis (NASH).{41875} It also decreases infarct volume and brain edema in a rat model of focal cerebral ischemia and reperfusion injury.{41876}
Brand:CaymanSKU:25091 - 50 mgAvailable on backorder
Calycosin 7-O-β-D-glucoside is an isoflavone glycoside that has been isolated from A. mongholicus and A. membranaceus and has antioxidant, anti-inflammatory, and neuroprotective biological activities.{43143,43144,43145} It scavenges 34.5% of generated 2,2-diphenyl-1-picrylhydrazyl (DPPH; Item No. 14805) radicals compared to a vehicle control when used at a concentration of 100 μg/ml in a cell-free assay.{43143} Calycosin 7-O-β-D-glucoside (10 μg/ml) inhibits cytotoxicity, intracellular reactive oxygen species (ROS) production, and cytoskeletal defects induced by LPS in human umbilical vein endothelial cells (HUVECs).{43144} In vivo, calycosin 7-O-β-D-glucoside (26.8 mg/kg) reduces brain infarct volume in a rat model of ischemia-reperfusion injury induced by middle cerebral artery occlusion (MCAO).{43145}
Brand:CaymanSKU:25095 - 1 mgAvailable on backorder
Calycosin 7-O-β-D-glucoside is an isoflavone glycoside that has been isolated from A. mongholicus and A. membranaceus and has antioxidant, anti-inflammatory, and neuroprotective biological activities.{43143,43144,43145} It scavenges 34.5% of generated 2,2-diphenyl-1-picrylhydrazyl (DPPH; Item No. 14805) radicals compared to a vehicle control when used at a concentration of 100 μg/ml in a cell-free assay.{43143} Calycosin 7-O-β-D-glucoside (10 μg/ml) inhibits cytotoxicity, intracellular reactive oxygen species (ROS) production, and cytoskeletal defects induced by LPS in human umbilical vein endothelial cells (HUVECs).{43144} In vivo, calycosin 7-O-β-D-glucoside (26.8 mg/kg) reduces brain infarct volume in a rat model of ischemia-reperfusion injury induced by middle cerebral artery occlusion (MCAO).{43145}
Brand:CaymanSKU:25095 - 10 mgAvailable on backorder
Calycosin 7-O-β-D-glucoside is an isoflavone glycoside that has been isolated from A. mongholicus and A. membranaceus and has antioxidant, anti-inflammatory, and neuroprotective biological activities.{43143,43144,43145} It scavenges 34.5% of generated 2,2-diphenyl-1-picrylhydrazyl (DPPH; Item No. 14805) radicals compared to a vehicle control when used at a concentration of 100 μg/ml in a cell-free assay.{43143} Calycosin 7-O-β-D-glucoside (10 μg/ml) inhibits cytotoxicity, intracellular reactive oxygen species (ROS) production, and cytoskeletal defects induced by LPS in human umbilical vein endothelial cells (HUVECs).{43144} In vivo, calycosin 7-O-β-D-glucoside (26.8 mg/kg) reduces brain infarct volume in a rat model of ischemia-reperfusion injury induced by middle cerebral artery occlusion (MCAO).{43145}
Brand:CaymanSKU:25095 - 25 mgAvailable on backorder
Calycosin 7-O-β-D-glucoside is an isoflavone glycoside that has been isolated from A. mongholicus and A. membranaceus and has antioxidant, anti-inflammatory, and neuroprotective biological activities.{43143,43144,43145} It scavenges 34.5% of generated 2,2-diphenyl-1-picrylhydrazyl (DPPH; Item No. 14805) radicals compared to a vehicle control when used at a concentration of 100 μg/ml in a cell-free assay.{43143} Calycosin 7-O-β-D-glucoside (10 μg/ml) inhibits cytotoxicity, intracellular reactive oxygen species (ROS) production, and cytoskeletal defects induced by LPS in human umbilical vein endothelial cells (HUVECs).{43144} In vivo, calycosin 7-O-β-D-glucoside (26.8 mg/kg) reduces brain infarct volume in a rat model of ischemia-reperfusion injury induced by middle cerebral artery occlusion (MCAO).{43145}
Brand:CaymanSKU:25095 - 5 mgAvailable on backorder
Calyculin A is a natural, cell-permeable inhibitor of the serine-threonine protein phosphatases (PP) PP1 and PP2A (IC50s = 0.3-0.7 and 0.5-1 nM, respectively).{32313,21678,32314} It is without significant effect against PP2B, PP2C, and PP4.{21678} Through its effects on PP1 and PP2A, calyculin A has been shown to either promote or inhibit cancer cell growth in tumor cell lines and animal models.{32312,18481}
Brand:CaymanSKU:-Available on backorder
Calyculin A is a natural, cell-permeable inhibitor of the serine-threonine protein phosphatases (PP) PP1 and PP2A (IC50s = 0.3-0.7 and 0.5-1 nM, respectively).{32313,21678,32314} It is without significant effect against PP2B, PP2C, and PP4.{21678} Through its effects on PP1 and PP2A, calyculin A has been shown to either promote or inhibit cancer cell growth in tumor cell lines and animal models.{32312,18481}
Brand:CaymanSKU:-Available on backorder
Camalexin is an alkaloid released by plants of the Brassicaceae family in response to pathogen infection.{35038} In addition to antimicrobial properties and a role in plant defense, camalexin exhibits antiproliferative activity in vitro against various cancer cell lines.{35039,35040,35041,35042} Camalexin is active against HeLa, Jurkat, MDA-MB-231, and CEM cancer cell lines (IC50s = 50.0, 46.2, 77.7, and 67.6 μM, respectively), but it is also toxic to primary human umbilical vein endothelial cells (HUVEC; (IC50 = 74.0 μM).{35040} Camalexin induces apoptosis in Jurkat cells by increasing reactive oxygen species (ROS) levels and activating caspase-8 and caspase-9.{35039} In human prostate cancer cell lines, camalexin (25 μM) is more active against aggressive lines and increases ROS levels and apoptosis via cathepsin D relocation from lysosomes to the cytosol.{35042,35043}
Brand:CaymanSKU:21971 -Out of stock
Camalexin is an alkaloid released by plants of the Brassicaceae family in response to pathogen infection.{35038} In addition to antimicrobial properties and a role in plant defense, camalexin exhibits antiproliferative activity in vitro against various cancer cell lines.{35039,35040,35041,35042} Camalexin is active against HeLa, Jurkat, MDA-MB-231, and CEM cancer cell lines (IC50s = 50.0, 46.2, 77.7, and 67.6 μM, respectively), but it is also toxic to primary human umbilical vein endothelial cells (HUVEC; (IC50 = 74.0 μM).{35040} Camalexin induces apoptosis in Jurkat cells by increasing reactive oxygen species (ROS) levels and activating caspase-8 and caspase-9.{35039} In human prostate cancer cell lines, camalexin (25 μM) is more active against aggressive lines and increases ROS levels and apoptosis via cathepsin D relocation from lysosomes to the cytosol.{35042,35043}
Brand:CaymanSKU:21971 -Out of stock
Camalexin is an alkaloid released by plants of the Brassicaceae family in response to pathogen infection.{35038} In addition to antimicrobial properties and a role in plant defense, camalexin exhibits antiproliferative activity in vitro against various cancer cell lines.{35039,35040,35041,35042} Camalexin is active against HeLa, Jurkat, MDA-MB-231, and CEM cancer cell lines (IC50s = 50.0, 46.2, 77.7, and 67.6 μM, respectively), but it is also toxic to primary human umbilical vein endothelial cells (HUVEC; (IC50 = 74.0 μM).{35040} Camalexin induces apoptosis in Jurkat cells by increasing reactive oxygen species (ROS) levels and activating caspase-8 and caspase-9.{35039} In human prostate cancer cell lines, camalexin (25 μM) is more active against aggressive lines and increases ROS levels and apoptosis via cathepsin D relocation from lysosomes to the cytosol.{35042,35043}
Brand:CaymanSKU:21971 -Out of stock
Cambendazol is an antihelmintic that, at a dose of 50 mg/kg/day in mice, eradicates S. ratti adult worms from intestine and S. stercoralis larva from muscle.{39137} It inhibits polymerization of microtubules isolated from bovine brain with an IC50 value of 64.2 µM.{39138} Formulations containing cambendazol have been used to treat strongyloidiasis in humans and have been studied as potential chemotherapeutics.{39136,39139}
Brand:CaymanSKU:20841 -Out of stock
Cambendazol is an antihelmintic that, at a dose of 50 mg/kg/day in mice, eradicates S. ratti adult worms from intestine and S. stercoralis larva from muscle.{39137} It inhibits polymerization of microtubules isolated from bovine brain with an IC50 value of 64.2 µM.{39138} Formulations containing cambendazol have been used to treat strongyloidiasis in humans and have been studied as potential chemotherapeutics.{39136,39139}
Brand:CaymanSKU:20841 -Out of stock
Cambendazol is an antihelmintic that, at a dose of 50 mg/kg/day in mice, eradicates S. ratti adult worms from intestine and S. stercoralis larva from muscle.{39137} It inhibits polymerization of microtubules isolated from bovine brain with an IC50 value of 64.2 µM.{39138} Formulations containing cambendazol have been used to treat strongyloidiasis in humans and have been studied as potential chemotherapeutics.{39136,39139}
Brand:CaymanSKU:20841 -Out of stock
Cambendazol is an antihelmintic that, at a dose of 50 mg/kg/day in mice, eradicates S. ratti adult worms from intestine and S. stercoralis larva from muscle.{39137} It inhibits polymerization of microtubules isolated from bovine brain with an IC50 value of 64.2 µM.{39138} Formulations containing cambendazol have been used to treat strongyloidiasis in humans and have been studied as potential chemotherapeutics.{39136,39139}
Brand:CaymanSKU:20841 -Out of stock
Camostat is a protease inhibitor.{26053,26054} It inhibits trypsin (Ki = 1 nM), as well as various inflammatory proteases, including plasmin, kallikrein, and thrombin. Camostat (50 µM) inhibits entry of vesicular stomatitis virus (VSV) particles pseudotyped with severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2 surface glycoprotein in Calu-3 cells and primary human lung epithelial cells.{49542} It reduces the number of SARS-CoV-2 genomic equivalents, a marker of infection, in Calu-3 cells. Camostat inhibits sodium channel function in human airway epithelial cells (IC50 = 50 nM) and enhances mucociliary clearance in sheep.{26503} Dietary administration of camostat (1 mg/kg) inhibits the production of TNF-α and chemokine (C-C motif) ligand 2 (CCL2) by monocytes, as well as proliferation of pancreatic stellate cells in a rat model of pancreatic fibrosis.{26054}
Brand:CaymanSKU:- Camostat is a protease inhibitor.{26053,26054} It inhibits trypsin (Ki = 1 nM), as well as various inflammatory proteases, including plasmin, kallikrein, and thrombin. Camostat (50 µM) inhibits entry of vesicular stomatitis virus (VSV) particles pseudotyped with severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2 surface glycoprotein in Calu-3 cells and primary human lung epithelial cells.{49542} It reduces the number of SARS-CoV-2 genomic equivalents, a marker of infection, in Calu-3 cells. Camostat inhibits sodium channel function in human airway epithelial cells (IC50 = 50 nM) and enhances mucociliary clearance in sheep.{26503} Dietary administration of camostat (1 mg/kg) inhibits the production of TNF-α and chemokine (C-C motif) ligand 2 (CCL2) by monocytes, as well as proliferation of pancreatic stellate cells in a rat model of pancreatic fibrosis.{26054}
Brand:CaymanSKU:- Camostat is a protease inhibitor.{26053,26054} It inhibits trypsin (Ki = 1 nM), as well as various inflammatory proteases, including plasmin, kallikrein, and thrombin. Camostat (50 µM) inhibits entry of vesicular stomatitis virus (VSV) particles pseudotyped with severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2 surface glycoprotein in Calu-3 cells and primary human lung epithelial cells.{49542} It reduces the number of SARS-CoV-2 genomic equivalents, a marker of infection, in Calu-3 cells. Camostat inhibits sodium channel function in human airway epithelial cells (IC50 = 50 nM) and enhances mucociliary clearance in sheep.{26503} Dietary administration of camostat (1 mg/kg) inhibits the production of TNF-α and chemokine (C-C motif) ligand 2 (CCL2) by monocytes, as well as proliferation of pancreatic stellate cells in a rat model of pancreatic fibrosis.{26054}
Brand:CaymanSKU:- Camostat is a protease inhibitor.{26053,26054} It inhibits trypsin (Ki = 1 nM), as well as various inflammatory proteases, including plasmin, kallikrein, and thrombin. Camostat (50 µM) inhibits entry of vesicular stomatitis virus (VSV) particles pseudotyped with severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2 surface glycoprotein in Calu-3 cells and primary human lung epithelial cells.{49542} It reduces the number of SARS-CoV-2 genomic equivalents, a marker of infection, in Calu-3 cells. Camostat inhibits sodium channel function in human airway epithelial cells (IC50 = 50 nM) and enhances mucociliary clearance in sheep.{26503} Dietary administration of camostat (1 mg/kg) inhibits the production of TNF-α and chemokine (C-C motif) ligand 2 (CCL2) by monocytes, as well as proliferation of pancreatic stellate cells in a rat model of pancreatic fibrosis.{26054}
Brand:CaymanSKU:-
Campestanol is a phytosterol found in vegetables, fruits, nuts, and seeds.{47133} Dietary administration of vegetable stanol esters (1% w/w) containing campestanol (30.1%) and sitostanol (65.7%; Item No. 26094) lower serum cholesterol, LDL, VLDL, and intermediate-density lipoprotein (IDL) cholesterol levels in an APOE*3-Leiden transgenic mouse model of atherosclerosis.{47134} This combination of campestanol with sitostanol also reduces atherosclerotic lesion area by 91% and the proportion of lesions with extensive macrophage infiltration.
Brand:CaymanSKU:26538 - 1 mgAvailable on backorder
Campestanol is a phytosterol found in vegetables, fruits, nuts, and seeds.{47133} Dietary administration of vegetable stanol esters (1% w/w) containing campestanol (30.1%) and sitostanol (65.7%; Item No. 26094) lower serum cholesterol, LDL, VLDL, and intermediate-density lipoprotein (IDL) cholesterol levels in an APOE*3-Leiden transgenic mouse model of atherosclerosis.{47134} This combination of campestanol with sitostanol also reduces atherosclerotic lesion area by 91% and the proportion of lesions with extensive macrophage infiltration.
Brand:CaymanSKU:26538 - 500 µgAvailable on backorder
Canagliflozin is an inhibitor of sodium-glucose cotransporter 2 (SGLT2; IC50 = 2.2 nM) that less potently blocks SGLT1 (IC50 = 910 nM).{18745} Canagliflozin is orally bioavailable and lowers plasma glucose by lowering the renal threshold for glucose and increasing urinary glucose excretion in animals.{18745,33510} Formulations containing SGLT2 inhibitors, including canagliflozin, are used to treat type 2 diabetes mellitus.{33509}
Brand:CaymanSKU:11575 - 10 mgAvailable on backorder
Canagliflozin is an inhibitor of sodium-glucose cotransporter 2 (SGLT2; IC50 = 2.2 nM) that less potently blocks SGLT1 (IC50 = 910 nM).{18745} Canagliflozin is orally bioavailable and lowers plasma glucose by lowering the renal threshold for glucose and increasing urinary glucose excretion in animals.{18745,33510} Formulations containing SGLT2 inhibitors, including canagliflozin, are used to treat type 2 diabetes mellitus.{33509}
Brand:CaymanSKU:11575 - 25 mgAvailable on backorder
Canagliflozin is an inhibitor of sodium-glucose cotransporter 2 (SGLT2; IC50 = 2.2 nM) that less potently blocks SGLT1 (IC50 = 910 nM).{18745} Canagliflozin is orally bioavailable and lowers plasma glucose by lowering the renal threshold for glucose and increasing urinary glucose excretion in animals.{18745,33510} Formulations containing SGLT2 inhibitors, including canagliflozin, are used to treat type 2 diabetes mellitus.{33509}
Brand:CaymanSKU:11575 - 5 mgAvailable on backorder
Canagliflozin is an inhibitor of sodium-glucose cotransporter 2 (SGLT2; IC50 = 2.2 nM) that less potently blocks SGLT1 (IC50 = 910 nM).{18745} Canagliflozin is orally bioavailable and lowers plasma glucose by lowering the renal threshold for glucose and increasing urinary glucose excretion in animals.{18745,33510} Formulations containing SGLT2 inhibitors, including canagliflozin, are used to treat type 2 diabetes mellitus.{33509}
Brand:CaymanSKU:11575 - 50 mgAvailable on backorder
Canagliflozin-d4 is intended for use as an internal standard for the quantification of canagliflozin (Item No. 11575) by GC- or LC-MS. Canagliflozin is an inhibitor of sodium-glucose cotransporter 2 (SGLT2; IC50 = 2.2 nM) that less potently blocks SGLT1 (IC50 = 910 nM).{18745} Canagliflozin is orally bioavailable and lowers plasma glucose by lowering the renal threshold for glucose and increasing urinary glucose excretion in animals.{18745,33510} Formulations containing SGLT2 inhibitors, including canagliflozin, have been used to treat type 2 diabetes mellitus.{33509}
Brand:CaymanSKU:25223 - 1 mgAvailable on backorder
Angiotensin receptor blockers effectively protect against the harmful effects of the activation of the renin-angiotensin-aldosterone system that occur with hypertension or diabetes.{18424} Candesartan cilexetil is a prodrug of the potent, long-acting, and selective angiotensin II type 1 receptor (AT1) antagonist, candesartan. It is rapidly hydrolyzed to candesartan during gastrointestinal absorption. Clinical trials indicate a 4-16 mg/day dose of candesartan cilexetil effectively reduces diastolic blood pressure.{18425} In addition to its anti-hypertensive properties, blockade of AT1 receptors with 10 mg/kg/day candesartan cilexetil in cold-restraint stressed SHR rats prevents stress-induced tyrosine hydroxylase transcription and increases AT2 receptor expression in the ventrolateral thalamic nucleus, suggesting a therapeutic role in stress-related disorders.{18423}
Brand:CaymanSKU:10489 - 1 gAvailable on backorder
Angiotensin receptor blockers effectively protect against the harmful effects of the activation of the renin-angiotensin-aldosterone system that occur with hypertension or diabetes.{18424} Candesartan cilexetil is a prodrug of the potent, long-acting, and selective angiotensin II type 1 receptor (AT1) antagonist, candesartan. It is rapidly hydrolyzed to candesartan during gastrointestinal absorption. Clinical trials indicate a 4-16 mg/day dose of candesartan cilexetil effectively reduces diastolic blood pressure.{18425} In addition to its anti-hypertensive properties, blockade of AT1 receptors with 10 mg/kg/day candesartan cilexetil in cold-restraint stressed SHR rats prevents stress-induced tyrosine hydroxylase transcription and increases AT2 receptor expression in the ventrolateral thalamic nucleus, suggesting a therapeutic role in stress-related disorders.{18423}
Brand:CaymanSKU:10489 - 10 gAvailable on backorder
Angiotensin receptor blockers effectively protect against the harmful effects of the activation of the renin-angiotensin-aldosterone system that occur with hypertension or diabetes.{18424} Candesartan cilexetil is a prodrug of the potent, long-acting, and selective angiotensin II type 1 receptor (AT1) antagonist, candesartan. It is rapidly hydrolyzed to candesartan during gastrointestinal absorption. Clinical trials indicate a 4-16 mg/day dose of candesartan cilexetil effectively reduces diastolic blood pressure.{18425} In addition to its anti-hypertensive properties, blockade of AT1 receptors with 10 mg/kg/day candesartan cilexetil in cold-restraint stressed SHR rats prevents stress-induced tyrosine hydroxylase transcription and increases AT2 receptor expression in the ventrolateral thalamic nucleus, suggesting a therapeutic role in stress-related disorders.{18423}
Brand:CaymanSKU:10489 - 5 gAvailable on backorder
Angiotensin receptor blockers effectively protect against the harmful effects of the activation of the renin-angiotensin-aldosterone system that occur with hypertension or diabetes.{18424} Candesartan cilexetil is a prodrug of the potent, long-acting, and selective angiotensin II type 1 receptor (AT1) antagonist, candesartan. It is rapidly hydrolyzed to candesartan during gastrointestinal absorption. Clinical trials indicate a 4-16 mg/day dose of candesartan cilexetil effectively reduces diastolic blood pressure.{18425} In addition to its anti-hypertensive properties, blockade of AT1 receptors with 10 mg/kg/day candesartan cilexetil in cold-restraint stressed SHR rats prevents stress-induced tyrosine hydroxylase transcription and increases AT2 receptor expression in the ventrolateral thalamic nucleus, suggesting a therapeutic role in stress-related disorders.{18423}
Brand:CaymanSKU:10489 - 500 mgAvailable on backorder
Candesartan-d4 is intended for use as an internal standard for the quantification of candesartan by GC- or LC-MS. Candesartan is an inhibitor of the angiotensin II type 1 (AT1) receptor (Kis = 0.17, 0.12, and 0.12 nM for human AT1, rat AT1A, and rat AT1B recombinant receptors, respectively).{28032} It is selective for AT1 over AT2 receptors (Ki = 26,500 nM for the human recombinant AT2 receptor). It inhibits angiotensin II-induced contraction of isolated rabbit aortic strips and increases in blood pressure in rats following intravenous administration (ID50 = 0.033 mg/kg).{42295} Candesartan is a metabolite of the orally bioavailable prodrug candesartan cilexetil (Item No. 10489). Formulations containing candesartan have been used in the treatment of hypertension and heart failure.
Brand:CaymanSKU:25419 - 1 mgAvailable on backorder
Candesartan-d4 is intended for use as an internal standard for the quantification of candesartan by GC- or LC-MS. Candesartan is an inhibitor of the angiotensin II type 1 (AT1) receptor (Kis = 0.17, 0.12, and 0.12 nM for human AT1, rat AT1A, and rat AT1B recombinant receptors, respectively).{28032} It is selective for AT1 over AT2 receptors (Ki = 26,500 nM for the human recombinant AT2 receptor). It inhibits angiotensin II-induced contraction of isolated rabbit aortic strips and increases in blood pressure in rats following intravenous administration (ID50 = 0.033 mg/kg).{42295} Candesartan is a metabolite of the orally bioavailable prodrug candesartan cilexetil (Item No. 10489). Formulations containing candesartan have been used in the treatment of hypertension and heart failure.
Brand:CaymanSKU:25419 - 5 mgAvailable on backorder
The HER family of receptor tyrosine kinases, EGFR, HER2, HER3, and HER4, mediate proliferation, migration, adhesion, differentiation, and survival in many different cell types and have been implicated in the development and progression of a variety of human tumors.{21790} Canertinib is an irreversible quinazoline-based HER family tyrosine kinase inhibitor with IC50 values of 0.8, 19, and 7 nM for blocking in vitro activity of EGFR, HER2, and HER4, respectively.{21790} As a broadly applicable anti-cancer agent, it has been used to suppress proliferation of malignant peripheral nerve sheath tumor cells (effective concentration of 250-500 nM), to inhibit growth and induce dose-dependent apoptosis in a panel of neuroblastoma cell lines (IC50s = 0.94-2.45 μM), and to reduce proliferation of acute myeloid leukemia cells (IC50 = 0.27 μM).{21791,21789,21793} Canertinib also displays anti-neoplastic activity towards T98G glioblastoma cells, HCT8 colorectal carcinoma cells, and cells expressing the breast cancer resistance protein.{21792}
Brand:CaymanSKU:12076 - 10 mgAvailable on backorder
The HER family of receptor tyrosine kinases, EGFR, HER2, HER3, and HER4, mediate proliferation, migration, adhesion, differentiation, and survival in many different cell types and have been implicated in the development and progression of a variety of human tumors.{21790} Canertinib is an irreversible quinazoline-based HER family tyrosine kinase inhibitor with IC50 values of 0.8, 19, and 7 nM for blocking in vitro activity of EGFR, HER2, and HER4, respectively.{21790} As a broadly applicable anti-cancer agent, it has been used to suppress proliferation of malignant peripheral nerve sheath tumor cells (effective concentration of 250-500 nM), to inhibit growth and induce dose-dependent apoptosis in a panel of neuroblastoma cell lines (IC50s = 0.94-2.45 μM), and to reduce proliferation of acute myeloid leukemia cells (IC50 = 0.27 μM).{21791,21789,21793} Canertinib also displays anti-neoplastic activity towards T98G glioblastoma cells, HCT8 colorectal carcinoma cells, and cells expressing the breast cancer resistance protein.{21792}
Brand:CaymanSKU:12076 - 25 mgAvailable on backorder
The HER family of receptor tyrosine kinases, EGFR, HER2, HER3, and HER4, mediate proliferation, migration, adhesion, differentiation, and survival in many different cell types and have been implicated in the development and progression of a variety of human tumors.{21790} Canertinib is an irreversible quinazoline-based HER family tyrosine kinase inhibitor with IC50 values of 0.8, 19, and 7 nM for blocking in vitro activity of EGFR, HER2, and HER4, respectively.{21790} As a broadly applicable anti-cancer agent, it has been used to suppress proliferation of malignant peripheral nerve sheath tumor cells (effective concentration of 250-500 nM), to inhibit growth and induce dose-dependent apoptosis in a panel of neuroblastoma cell lines (IC50s = 0.94-2.45 μM), and to reduce proliferation of acute myeloid leukemia cells (IC50 = 0.27 μM).{21791,21789,21793} Canertinib also displays anti-neoplastic activity towards T98G glioblastoma cells, HCT8 colorectal carcinoma cells, and cells expressing the breast cancer resistance protein.{21792}
Brand:CaymanSKU:12076 - 5 mgAvailable on backorder
The HER family of receptor tyrosine kinases, EGFR, HER2, HER3, and HER4, mediate proliferation, migration, adhesion, differentiation, and survival in many different cell types and have been implicated in the development and progression of a variety of human tumors.{21790} Canertinib is an irreversible quinazoline-based HER family tyrosine kinase inhibitor with IC50 values of 0.8, 19, and 7 nM for blocking in vitro activity of EGFR, HER2, and HER4, respectively.{21790} As a broadly applicable anti-cancer agent, it has been used to suppress proliferation of malignant peripheral nerve sheath tumor cells (effective concentration of 250-500 nM), to inhibit growth and induce dose-dependent apoptosis in a panel of neuroblastoma cell lines (IC50s = 0.94-2.45 μM), and to reduce proliferation of acute myeloid leukemia cells (IC50 = 0.27 μM).{21791,21789,21793} Canertinib also displays anti-neoplastic activity towards T98G glioblastoma cells, HCT8 colorectal carcinoma cells, and cells expressing the breast cancer resistance protein.{21792}
Brand:CaymanSKU:12076 - 50 mgAvailable on backorder
Cangrelor is an ATP analog that inhibits platelet aggregation (IC50 = 0.4 nM).{40206} It is a reversible competitive antagonist of the platelet purinergic P2Y12 receptor.{23699,40207} Pretreatment with cangrelor significantly reduces blood clotting induced by ADP in a mouse model of pulmonary thromboembolism.{40208} Formulations containing cangrelor have been used to prevent blood clotting in at-risk patients.{40209}
Brand:CaymanSKU:22086 -Out of stock
Lipoxygenases (LOs) are non-heme iron-containing dioxygenases that catalyze the oxidation of polyunsaturated fatty acids to generate unsaturated fatty acid hydroperoxides.{346} The immediate products of 15-LO fatty acid oxidation act as mediators in inflammation, thrombosis, and cancer.{1462} CBDD is a cannabidiol derivative that potently and selectively inhibits 15-LO with an IC50 value of 0.28 µM.{17111} It does not inhibit 5-LO effectively (IC50 >200 µM).{17111}
Brand:CaymanSKU:- Lipoxygenases (LOs) are non-heme iron-containing dioxygenases that catalyze the oxidation of polyunsaturated fatty acids to generate unsaturated fatty acid hydroperoxides.{346} The immediate products of 15-LO fatty acid oxidation act as mediators in inflammation, thrombosis, and cancer.{1462} CBDD is a cannabidiol derivative that potently and selectively inhibits 15-LO with an IC50 value of 0.28 µM.{17111} It does not inhibit 5-LO effectively (IC50 >200 µM).{17111}
Brand:CaymanSKU:- Lipoxygenases (LOs) are non-heme iron-containing dioxygenases that catalyze the oxidation of polyunsaturated fatty acids to generate unsaturated fatty acid hydroperoxides.{346} The immediate products of 15-LO fatty acid oxidation act as mediators in inflammation, thrombosis, and cancer.{1462} CBDD is a cannabidiol derivative that potently and selectively inhibits 15-LO with an IC50 value of 0.28 µM.{17111} It does not inhibit 5-LO effectively (IC50 >200 µM).{17111}
Brand:CaymanSKU:- Lipoxygenases (LOs) are non-heme iron-containing dioxygenases that catalyze the oxidation of polyunsaturated fatty acids to generate unsaturated fatty acid hydroperoxides.{346} The immediate products of 15-LO fatty acid oxidation act as mediators in inflammation, thrombosis, and cancer.{1462} CBDD is a cannabidiol derivative that potently and selectively inhibits 15-LO with an IC50 value of 0.28 µM.{17111} It does not inhibit 5-LO effectively (IC50 >200 µM).{17111}
Brand:CaymanSKU:-
Cannabidiolic acid methyl ester (Item No. 28347) is an analytical reference standard that is the methyl ester form of cannabidiolic acid (Item No. 18090). Cannabidiolic acid methyl ester has analgesic activity in rats.{52792} This product is intended for research and forensic applications.
Brand:CaymanSKU:28347 - 1 mgAvailable on backorder
Cannabidiolic acid methyl ester (Item No. 28347) is an analytical reference standard that is the methyl ester form of cannabidiolic acid (Item No. 18090). Cannabidiolic acid methyl ester has analgesic activity in rats.{52792} This product is intended for research and forensic applications.
Brand:CaymanSKU:28347 - 5 mgAvailable on backorder
Cannabielsoin (Item No. 21092) is an analytical reference standard categorized as a phytocannabinoid metabolite.{61035,61036} Cannabielsoin is a metabolite of cannabidiol (CBD; Item Nos. ISO60156 | 90080). This product is intended for research and forensic applications.
Brand:CaymanSKU:21092 -Out of stock
Cannabielsoin (Item No. 21092) is an analytical reference standard categorized as a phytocannabinoid metabolite.{61035,61036} Cannabielsoin is a metabolite of cannabidiol (CBD; Item Nos. ISO60156 | 90080). This product is intended for research and forensic applications.
Brand:CaymanSKU:21092 -Out of stock
Cannabigerorcin (Item No. 23257) is an analytical reference standard categorized as a phytocannabinoid.{38471} This product is intended for research and forensic applications. This item has been tested to contain ≤0.3% Δ9-THC on a dry weight basis meeting the 2018 Farm Bill requirements to be a non-controlled substance in the U.S.
Brand:CaymanSKU:23257 - 1 mgAvailable on backorder
Cannabigerorcin (Item No. 23257) is an analytical reference standard categorized as a phytocannabinoid.{38471} This product is intended for research and forensic applications. This item has been tested to contain ≤0.3% Δ9-THC on a dry weight basis meeting the 2018 Farm Bill requirements to be a non-controlled substance in the U.S.
Brand:CaymanSKU:23257 - 5 mgAvailable on backorder
Cannabigerorcinic acid (Item No. 23258) is an analytical reference standard that is structurally similar to known phytocannabinoids. Cannabigerorcinic acid is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications. This item has been tested to contain ≤0.3% Δ9-THC on a dry weight basis meeting the 2018 Farm Bill requirements to be a non-controlled substance in the U.S.
Brand:CaymanSKU:23258 - 1 mgAvailable on backorder
Cannabigerorcinic acid (Item No. 23258) is an analytical reference standard that is structurally similar to known phytocannabinoids. Cannabigerorcinic acid is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications. This item has been tested to contain ≤0.3% Δ9-THC on a dry weight basis meeting the 2018 Farm Bill requirements to be a non-controlled substance in the U.S.
Brand:CaymanSKU:23258 - 5 mgAvailable on backorder
Cannabinodiol (Item No. 9002479) is an analytical reference standard that is categorized as a phytocannabinoid. It is an aromatic compound that has been isolated from Lebanese hashish.{30516} The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic applications. This item has been tested to contain ≤0.3% Δ9-THC on a dry weight basis meeting the 2018 Farm Bill requirements to be a non-controlled substance in the U.S.
Brand:CaymanSKU:9002479 - 1 mgAvailable on backorder
Cannabinodiol (Item No. 9002479) is an analytical reference standard that is categorized as a phytocannabinoid. It is an aromatic compound that has been isolated from Lebanese hashish.{30516} The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic applications. This item has been tested to contain ≤0.3% Δ9-THC on a dry weight basis meeting the 2018 Farm Bill requirements to be a non-controlled substance in the U.S.
Brand:CaymanSKU:9002479 - 10 mgAvailable on backorder
Cannabinodiol (Item No. 9002479) is an analytical reference standard that is categorized as a phytocannabinoid. It is an aromatic compound that has been isolated from Lebanese hashish.{30516} The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic applications. This item has been tested to contain ≤0.3% Δ9-THC on a dry weight basis meeting the 2018 Farm Bill requirements to be a non-controlled substance in the U.S.
Brand:CaymanSKU:9002479 - 5 mgAvailable on backorder
Cannabinol (Item No. 25495) is an analytical reference standard categorized as a phytocannabinoid.{27531} This product is intended for research and forensic applications. This item has been tested to contain ≤0.3% Δ9-THC on a dry weight basis meeting the 2018 Farm Bill requirements to be a non-controlled substance in the US.
Brand:CaymanSKU:25495 - 10 mgAvailable on backorder
Cannabinol (Item No. 25495) is an analytical reference standard categorized as a phytocannabinoid.{27531} This product is intended for research and forensic applications. This item has been tested to contain ≤0.3% Δ9-THC on a dry weight basis meeting the 2018 Farm Bill requirements to be a non-controlled substance in the US.
Brand:CaymanSKU:25495 - 50 mgAvailable on backorder
Cannabinol monomethyl ether (Item No. 9002480) is an analytical reference standard that is categorized as a phytocannabinoid. It can be isolated from Cannabis plants, derived from cannabinol (Item No. ISO60183), or synthesized.{30521,30522,30523} The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic applications.
Brand:CaymanSKU:9002480 - 1 mgAvailable on backorder
Cannabinol monomethyl ether (Item No. 9002480) is an analytical reference standard that is categorized as a phytocannabinoid. It can be isolated from Cannabis plants, derived from cannabinol (Item No. ISO60183), or synthesized.{30521,30522,30523} The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic applications.
Brand:CaymanSKU:9002480 - 10 mgAvailable on backorder
Cannabinol monomethyl ether (Item No. 9002480) is an analytical reference standard that is categorized as a phytocannabinoid. It can be isolated from Cannabis plants, derived from cannabinol (Item No. ISO60183), or synthesized.{30521,30522,30523} The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic applications.
Brand:CaymanSKU:9002480 - 5 mgAvailable on backorder